Search results
The Implantable Loop Recorder
Author(s):
Richard Sutton
,
Michele Brignole
Added:
3 years ago
Article
Author(s):
Harold Djodjo Kano
,
Wei Sun
Added:
5 months ago
Author(s):
Barbara Stähli
Added:
7 months ago
ESC 2023 — Prof Barbara Stähli (University Hospital Zurich, CH) joins us onsite at ESC 23 to outline the findings of the MULTISTARS AMI Trial (NCT03135275).
MULTISTARS AMI aimed to compare the safety and efficacy of two treatment strategies currently performed in clinical practice, immediate complete revascularization versus staged complete revascularization in patients presenting with ST…
View more
Author(s):
Thomas D Giles
Added:
3 years ago
Introduction
The concept of 'hypertensionÔÇÖ as a clinical entity has been a work in progress for decades. At some point, the diagnosis of hypertension began to be linked to specific levels of blood pressure. The Joint National Committee (JNCI-JNC7) reports provide a perspective and an understanding that a clearer and precise definition might avoid the dead-end that the current concept of…
View more
Author(s):
Martha Gulati
Added:
1 year ago
ESC Congress 2022 — In this short and practice-focused review, Dr Martha Gulati, Associate Director of the Barbra Streisand Women Heart Center and Director of CVD Prevention(Cedars-Sinai Medical Center, US) shares some her thoughts on the top 3 hot line trials.
Trials covered in detail include:
00:27: TIME:The Treatment in Morning versus Evening
01:57: SECURE:A polypill strategy in secondary…
View more
Author(s):
Paul Kalra
Added:
10 months ago
ESC-HFA 23 – Prof Paul Kalra (Portsmouth Hospitals NHS Trust, UK) joins us onsite to discuss the IRONMAN trial (NCT02642562).
The IRONMAN trial aimed to study the effectiveness of intravenous iron in patients with heart failure and iron deficiency when compared to standard care. It showed that administration of IV FDI led to lower rates of recurrent heart failure hospitalisations and…
View more
Pedro Brugada
Research Area(s) / Expertise:
Job title: Head of Heart Rhythm Management Centre
Author
Author(s):
James L Januzzi
Added:
3 years ago
The use of natriuretic peptide testing has dramatically risen recently, in recognition of the value of these blood tests for assisting in the evaluation of patients with suspected heart failure (HF). B-type natriuretic peptide (BNP) is formed as a consequence of production of a 108-amino-acid precursor peptide that is synthesised within the cardiomyocyte; this 'pro-BNP108' is subsequently cleaved…
View more
Author(s):
James L Januzzi
Added:
3 years ago
The use of natriuretic peptide testing has dramatically risen recently, in recognition of the value of these blood tests for assisting in the evaluation of patients with suspected heart failure (HF). B-type natriuretic peptide (BNP) is formed as a consequence of production of a 108-amino-acid precursor peptide that is synthesised within the cardiomyocyte; this 'pro-BNP108' is subsequently cleaved…
View more
Author(s):
Paul A Friedman
,
Stephen C Hammill
Added:
3 years ago
Atrial fibrillation (AF) is a rhythm disturbance of the atria that results in irregular, chaotic, ventricular waveforms, varying from bradyarrhythmia to tachyarrhythmia. Essentially, all forms of AF therapy can be divided into two categories - restoration and maintenance of normal sinus rhythm, or control of the ventricular rate while permitting on-going fibrillation of the atria. Although…
View more